wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34983601-056BBDDF-199E-4DFD-B3D2-AC4755B856F6
Q34983601-056BBDDF-199E-4DFD-B3D2-AC4755B856F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34983601-056BBDDF-199E-4DFD-B3D2-AC4755B856F6
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.
P2860
Q34983601-056BBDDF-199E-4DFD-B3D2-AC4755B856F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34983601-056BBDDF-199E-4DFD-B3D2-AC4755B856F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dbcdee6f16a60501b2995f5ccf84fa9448220acd
P2860
Clinical characteristics and prognostic analysis of triple-negative breast cancer patients.